Anti-Saccharomyces Cerevisiae Antibody (ASCA) is a Useful Diagnostic Tool to Differentiate Crohn's Disease From Intestinal Tuberculosis

被引：0
|
作者：
Kim, You Sun
Kim, Beom Jin
Kim, Young-Ho
Kim, Won Ho
Kim, Joo Sung
Park, Young-Sook
Yang, Suk-Kyun
Ye, Byong Duk
Jang, Byung-Ik
Jung, Sung-Ae
Jeen, Yoon Tae
Cheon, Jae Hee
Choi, Yong Sung
Choi, Jai Hyun
Choi, Chang Hwan
Han, Dong Soo
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T1284
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [21] Association between anti-Saccharomyces Cerevisiae antibodies (ASCA) and clinical patterns of Crohn's disease (CD).
    Sambuelli, AM
    Negreira, S
    Villalva, S
    Gil, A
    Huernos, S
    Bai, J
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A178 - A179
  • [22] Likelihood Ratio for Crohn's Disease as a Function of Anti-Saccharomyces cerevisiae Antibody Concentration
    Vermeulen, N.
    Vermeire, S.
    Rutgeerts, P.
    Bossuyt, X.
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (01) : 5 - 6
  • [23] Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease
    Standaert-Vitse, Annie
    Jouault, Thierry
    Vandewalle, Peggy
    Mille, Celine
    Seddik, Mimouna
    Sendid, Boualem
    Mallet, Jean-Maurice
    Colombel, Jean-Frederic
    Poulain, Daniel
    [J]. GASTROENTEROLOGY, 2006, 130 (06) : 1764 - 1775
  • [24] Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease
    Oshitani, N
    Hato, F
    Matsumoto, T
    Jinno, Y
    Sawa, Y
    Hara, J
    Nakamura, S
    Seki, S
    Arakawa, T
    Kitano, A
    Kitagawa, S
    Kuroki, T
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (12) : 1400 - 1403
  • [25] Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease
    Vermeire, S
    Joossens, S
    Peeters, M
    Monsuur, F
    Marien, G
    Bossuyt, X
    Groenen, P
    Vlietinck, R
    Rutgeerts, P
    [J]. GASTROENTEROLOGY, 2001, 120 (04) : 827 - 833
  • [26] Stratification of Crohn's disease by antineutrophil cytoplasmic antibodies (ANCA) & anti-Saccharomyces cerevisiae antibody (ASCA) distinguishes phenotypic subgroups.
    Vasiliauskas, EA
    Plevy, SE
    Targan, SR
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1112 - A1112
  • [27] Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease
    Le Goff, C.
    Chapelle, J. P.
    Lutteri, L.
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2007, 65 (06) : 601 - 608
  • [28] Anti-saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: Stability over time and correlation with clinical characteristics
    Bitton, A
    Vermeire, S
    Edwardes, MD
    Dubresne, L
    Villiani, C
    Wild, G
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A194 - A194
  • [29] Stratification Crohn's disease (CD) patients according to their ASCA (anti-Saccharomyces cerevisiae antibodies) expression.
    Joossens, S
    Vermeire, S
    Claessens, G
    Loos, R
    Pierik, M
    Esters, N
    Bossuyt, X
    Rutgeerts, P
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A266 - A266
  • [30] ASCA (anti-Saccharomyces cerevisiae antibodies) in healthy relatives of sporadic and familial Crohn's disease patients.
    Joossens, S
    Vermeire, S
    Vandewalle, P
    Esters, N
    Sendid, B
    Poulain, D
    Colombel, JF
    Rutgeerts, P
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A525 - A525
12345